Agackiran, Y. Et Al. 2021. Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.17, no.3 , 280-288.

Agackiran, Y., Aksu, F., Akyürek, N., Ercan, C., Demiroz, M., & Aksu, K., (2021). Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.17, no.3, 280-288.

Agackiran, Yetkin Et Al. "Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma," ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.17, no.3, 280-288, 2021

Agackiran, Yetkin Et Al. "Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma." ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.17, no.3, pp.280-288, 2021

Agackiran, Y. Et Al. (2021) . "Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma." ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.17, no.3, pp.280-288.

@article{article, author={Yetkin Agackiran Et Al. }, title={Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma}, journal={ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY}, year=2021, pages={280-288} }